Suzuki, Nami
Oota-Ishigaki, Akiko
Kaizuka, Toshie
Itoh, Masayuki
Yamazaki, Maya
Natsume, Rie
Abe, Manabu
Sakimura, Kenji
Mishina, Masayoshi
Hayashi, Takashi http://orcid.org/0000-0003-3591-2109
Funding for this research was provided by:
Japan Society for the Promotion of Science (22680029, 23650187, 24111512, 16K07078, 21249012, 22123008, 24249014, 16H04676, 21300118, 24650195, 24700321, 26350979)
Japan Agency for Medical Research and Development (JP18gm5910009, JP20gm4010004)
Mitsubishi Foundation
Brain Science Foundation
Suzuken Memorial Foundation
Astellas Foundation for Research on Metabolic Disorders
Takeda Science Foundation
Article History
Received: 23 October 2023
Accepted: 1 April 2024
First Online: 9 April 2024
Declarations
:
: All animal care and experiments were performed in accordance with the regulations and institutional guidelines of Niigata University, the University of Tokyo, the National Center of Neurology and Psychiatry (NCNP), the National Institute of Advanced Industrial Science and Technology (AIST), the Japanese Pharmacological Society, and the Japan Neuroscience Society. The technical protocols for animal experiments in this study were approved by the institutional review committees of the Graduate School of Medicine, the University of Tokyo, National Institute of Neuroscience, NCNP, and AIST.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.